Stanford Autonomic Disorders Program Clinical Trials

Natural History Study of Synucleinopathies
PI: Mitchell Miglis, MD
Study Status: Open to enrollment
Research Coordinator: Ruba Shaik or Jordan Seliger
Contact: rubas@stanford.edu or jseliger@stanford.edu

A Phase 3, 4-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of TD-9855 in Treating Symptomatic Neurogenic Orthostatic Hypotension in Subjects With Primary Autonomic Failure
PI: Dong-In Sinn, MD
NCT03750552
Study Status: Open to enrollment
Research Coordinator: Ruba Shaik or Jordan Seliger
Contact: rubas@stanford.edu or jseliger@stanford.edu

A Phase 3, 22-week, Multi-center, Randomized Withdrawal Study of TD˗9855 in Treating Symptomatic Neurogenic Orthostatic Hypotension in Subjects with Primary Autonomic Failure
PI: Dong-In Sinn, MD
NCT03829657
Study Status: Open to enrollment
Research Coordinator: Ruba Shaik or Jordan Seliger
Contact: rubas@stanford.edu or  jseliger@stanford.edu

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of BHV-3241 in Subjects With Multiple System Atrophy
PI: Mitchell Miglis, MD
NCT03952806
Study Status: Closed to enrollment
Research Coordinator: Ruba Shaik or Jordan Seliger
Contact: rubas@stanford.edu or  jseliger@stanford.edu